Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform
Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), and Foghorn Therapeutics […]
Equine Sarcoids - Visible Success with DelNS-based Immunotherapy Leads the Way Towards Cancer Therapy in Humans
Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS […]
FDA Approves NGS-Based Companion Diagnostic for EGFR Exon20 Insertion Mutant Non-Small Cell Lung Cancer Tumor Tissue
The U.S. Food and Drug Administration (FDA) has granted premarket approval to Thermo Fisher Scientific‘s Oncomine Dx Target […]
Vinehealth Raises $5.5m to Improve the Quality of Life and Survival of Cancer Patients
Today, Vinehealth announces it has raised $5.5m in seed funding. The round was led by […]
On Target Laboratories Announces FDA Approval of CYTALUX ™ (pafolacianine) Injection for Identification of Ovarian Cancer During Surgery
On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent imaging agents to target and […]
Blueprint Medicines to Expand Precision Therapy Leadership in Lung Cancer with Acquisition of Lengo Therapeutics
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that the company has entered into a definitive agreement […]
Novarad Partners with CureMetrix to Advance AI-Driven Mammography
Novarad, a leader in the development of medical imaging software, today announced a partnership with […]
Therapixel Receives FDA Clearance for Use of its AI-based Breast Cancer Screening Software MammoScreen® on Digital Breast Tomosynthesis
Therapixel, a company leading the use of AI-based products for women’s health, announces it has […]
Targeted Drug Recommended to Treat Some Advanced Lung Cancer Patients
The National Institute for Health and Care Excellence (NICE) has recommended the use of selpercatinib (Retevmo) for […]
Starpharma Releases Positive DEP® Cabazitaxel Phase 2 Interim Results in Prostate Cancer
Melbourne biotech company Starpharma today announced positive interim results from the prostate cancer cohort in its ongoing […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more